Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
2,149,205
-
Share change
-
+769
-
Total reported value
-
$44,080,900
-
Price per share
-
$20.51
-
Number of holders
-
47
-
Value change
-
+$15,105
-
Number of buys
-
24
-
Number of sells
-
17
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2025
As of 30 Jun 2025,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,149,205 shares.
The largest 10 holders included
UBS Group AG, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES FINANCIAL INC, MORGAN STANLEY, Portland Global Advisors LLC, Royal Bank of Canada, Clearwater Capital Advisors, LLC, AMERIPRISE FINANCIAL INC, and LPL Financial LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.